Name
*
First Name
Last Name
Credentials
*
Email
*
example@example.com
1. Which best defines minimal symptom expression (MSE) in generalized myasthenia gravis?
*
a. QMG score ≤ 3
b. MG-ADL score of 0 or 1 with minimal medication side effects
c. No detectable acetylcholine receptor antibodies on serology
d. Ability to perform all activities of daily living without rest
2. What is the principal therapeutic mechanism of FcRn inhibitors in antibody-mediated diseases such as gMG?
*
a. Blocking complement activation at the neuromuscular junction
b. Depleting B cells that produce pathogenic autoantibodies
c. Preventing FcRn-mediated IgG recycling, increasing IgG catabolism and lowering pathogenic IgG levels
d. Directly neutralizing autoantibodies by binding the antigen-recognition site
3. Which statement best reflects emerging data on FcRn inhibitors in special populations with gMG?
*
a. FcRn inhibitors are effective only in AChR-positive patients and show no benefit in other antibody subtypes
b. Early data suggest efficacy in MuSK-positive and some seronegative gMG, with subgroup sizes still limited in pivotal trials
c. FcRn inhibitors are contraindicated in pediatric patients due to absent pharmacodynamic response
d. FcRn inhibitors have replaced IVIG and plasma exchange as standard of care in myasthenic crisis
Please rate the extent to which this activity met the following objectives:
Rows
Poor
Fair
Good
Very Good
Excellent
Review the disease burden and unmet needs of patients with gMG and specific QoL measures including minimal symptom expression (MSE)
Evaluate the current clinical trial data for gMG therapeutics and use of MSE in order to measure disease activity and guide progress towards treatment goals
Develop individualized treatment plans for FcRn blockers including the role of pre-filled self-injection routes of administration to improve outcomes
Please provide us with feedback regarding your experience at the activity:
Rows
Poor
Fair
Good
Very Good
Excellent
Overall Program
Content
Usefulness
Please rate the faculty on their overall teaching ability:
Rows
Poor
Fair
Good
Very Good
Excellent
Min K. Kang, MD
Do you feel this activity was fair balanced and free of commercial bias?
Yes
No
If no, please explain:
This educational activity will result in a change in my role as a healthcare team member.
Yes
No
N/A
Based on your participation in this activity, choose the statement(s) that applies to how your role as a healthcare team member will change:
I gained new strategies/skills/information that my team can apply to practice
I plan to implement new strategies/skills/information in my practice
I will be more competent in my team’s management of patient care
I will improve my communication with the healthcare team
What factors beyond clinical care that effect the health of your patients does your team experience?
Course Title
Date
Credits
Credit Type
Submit
Should be Empty: